###begin article-title 0
Interleukin-17A Mediates Acquired Immunity to Pneumococcal Colonization
###end article-title 0
###begin p 1
Co-senior authors.
###end p 1
###begin p 2
Conceived and designed the experiments: YJL JG DB AF LB QZ JKK AS AL CMT KFH PWA ML RM. Performed the experiments: YJL JG DB AF LB QZ AS AL SF CMT PWA ML RM. Analyzed the data: YJL JG DB AF LB QZ JKK AS AL SF CMT PWA ML RM. Contributed reagents/materials/analysis tools: YJL DB JKK KFH RM. Wrote the paper: PWA ML RM.
###end p 2
###begin p 3
###xml 669 672 669 672 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 863 871 859 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 1114 1121 1110 1117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1469 1477 1465 1473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 83 91 <span type="species:ncbi:9606">children</span>
###xml 268 272 <span type="species:ncbi:10090">mice</span>
###xml 673 677 <span type="species:ncbi:10090">mice</span>
###xml 737 741 <span type="species:ncbi:10090">mice</span>
###xml 799 803 <span type="species:ncbi:10090">mice</span>
###xml 831 835 <span type="species:ncbi:10090">mice</span>
###xml 965 969 <span type="species:ncbi:10090">mice</span>
###xml 1088 1092 <span type="species:ncbi:10090">mice</span>
###xml 1193 1201 <span type="species:ncbi:9606">children</span>
###xml 1278 1283 <span type="species:ncbi:9606">human</span>
###xml 1424 1428 <span type="species:ncbi:10090">mice</span>
###xml 1445 1451 <span type="species:ncbi:9606">humans</span>
Although anticapsular antibodies confer serotype-specific immunity to pneumococci, children increase their ability to clear colonization before these antibodies appear, suggesting involvement of other mechanisms. We previously reported that intranasal immunization of mice with pneumococci confers CD4+ T cell-dependent, antibody- and serotype-independent protection against colonization. Here we show that this immunity, rather than preventing initiation of carriage, accelerates clearance over several days, accompanied by neutrophilic infiltration of the nasopharyngeal mucosa. Adoptive transfer of immune CD4+ T cells was sufficient to confer immunity to naive RAG1-/- mice. A critical role of interleukin (IL)-17A was demonstrated: mice lacking interferon-gamma or IL-4 were protected, but not mice lacking IL-17A receptor or mice with neutrophil depletion. In vitro expression of IL-17A in response to pneumococci was assayed: lymphoid tissue from vaccinated mice expressed significantly more IL-17A than controls, and IL-17A expression from peripheral blood samples from immunized mice predicted protection in vivo. IL-17A was elicited by pneumococcal stimulation of tonsillar cells of children or adult blood but not cord blood. IL-17A increased pneumococcal killing by human neutrophils both in the absence and in the presence of antibodies and complement. We conclude that IL-17A mediates pneumococcal immunity in mice and probably in humans; its elicitation in vitro could help in the development of candidate pneumococcal vaccines.
###end p 3
###begin title 4
Author Summary
###end title 4
###begin p 5
###xml 14 38 14 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae</italic>
###xml 831 832 831 832 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 955 956 955 956 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 14 38 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
###xml 80 88 <span type="species:ncbi:9606">children</span>
###xml 257 265 <span type="species:ncbi:9606">children</span>
###xml 583 588 <span type="species:ncbi:10090">mouse</span>
###xml 744 750 <span type="species:ncbi:9606">humans</span>
###xml 878 883 <span type="species:ncbi:9606">human</span>
###xml 985 993 <span type="species:ncbi:9606">children</span>
###xml 1077 1083 <span type="species:ncbi:9606">humans</span>
###xml 1174 1180 <span type="species:ncbi:9606">humans</span>
The bacterium Streptococcus pneumoniae (pneumococcus) causes serious disease in children and the elderly, including pneumonia and meningitis (inflammation of the brain). Carriage of pneumococcus in the nose is a necessary first step for most infections. As children age, they carry pneumococcus for shorter periods of time and their risk of disease decreases also. The mechanisms underlying this age-related decrease of carriage are not well understood. A deeper understanding of resistance to colonization would enable us to develop better pneumococcal vaccines. Using experimental mouse models, we show that repeated exposure to pneumococci leads to a subsequent reduction in duration of pneumococcal carriage, similar to what is observed in humans. We identify the immune cells that are responsible for this process, so-called TH17 cells, which release a factor that enables human blood cells to kill pneumococcus more efficiently. We show that these TH17 cells exist in adults and children, but not in newborn babies, which suggests that they may arise as a consequence of humans being exposed to pneumococcus. We describe an assay for the measurement of these cells in humans. Such an assay could facilitate the development of novel vaccines directed against pneumococcal carriage.
###end p 5
###begin title 6
Introduction
###end title 6
###begin p 7
###xml 0 24 0 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae</italic>
###xml 277 280 277 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Lord1">[1]</xref>
###xml 351 354 351 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Black1">[2]</xref>
###xml 355 358 355 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Dagan1">[3]</xref>
###xml 565 568 565 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Goldblatt1">[4]</xref>
###xml 569 572 569 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Weinberger1">[5]</xref>
###xml 981 984 981 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Lipsitch1">[6]</xref>
###xml 1115 1118 1115 1118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Hogberg1">[7]</xref>
###xml 1263 1266 1263 1266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Dagan2">[8]</xref>
###xml 1543 1546 1543 1546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Lipsitch1">[6]</xref>
###xml 1547 1550 1547 1550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Hogberg1">[7]</xref>
###xml 1565 1568 1565 1568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-McCool1">[9]</xref>
###xml 1569 1573 1569 1573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-McCool2">[10]</xref>
###xml 1592 1595 1592 1595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Goldblatt1">[4]</xref>
###xml 1596 1600 1596 1600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Malley1">[11]</xref>
###xml 1997 2001 1997 2001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Briles1">[12]</xref>
###xml 2002 2006 2002 2006 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Ogunniyi1">[13]</xref>
###xml 2007 2011 2007 2011 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Briles2">[14]</xref>
###xml 2012 2016 2012 2016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Simell1">[15]</xref>
###xml 2017 2021 2017 2021 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Rapola1">[16]</xref>
###xml 2022 2026 2022 2026 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Simell2">[17]</xref>
###xml 0 24 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
###xml 410 416 <span type="species:ncbi:9606">humans</span>
###xml 1534 1542 <span type="species:ncbi:9606">children</span>
###xml 1963 1968 <span type="species:ncbi:9606">human</span>
Streptococcus pneumoniae (pneumococcus) is an "extracellular" pathogen, generally considered to be killed by phagocytic ingestion, which is facilitated by opsonic antibodies. The success of anti-pneumococcal serum therapy using passive transfer of serotype-specific antibodies [1] and of vaccinations based on purified or conjugated capsular antigens [2],[3] clearly shows that anticapsular antibodies protect humans against pneumococcal colonization and disease. There is good epidemiologic evidence for the importance of such immunity in certain common serotypes [4],[5]. However, we and others have found that factors other than anticapsular antibodies may play a role in the natural development of protection against pneumococcal colonization and disease. First, the reduction in pneumococcal disease incidence after the first year of life occurs simultaneously for both rare and common serotypes, suggesting the acquisition of one rather than many individual immune responses [6]. Similarly, the duration of carriage of many serotypes declines steeply between the first and second birthdays for many serotypes [7]. Since experience with conjugate vaccines has suggested that anticapsular antibodies reduce incidence of carriage but leave duration unaffected [8], this observation also suggests a mechanism of acquired immunity other than anticapsular antibodies. Moreover, the declines in carriage duration and invasive disease incidence precede by several years the detection of naturally-acquired anticapsular antibody in most children [6],[7]. Experimental [9],[10] and observational [4],[11] studies in adults have found little or no evidence that higher anticapsular antibody concentrations are associated with greater protection from colonization. Pneumococci also express non-capsular antigens common among serotypes, and certain of these have been found to elicit antibodies with protective potential in animal models. The role of such antibodies in human immunity has been evaluated [12],[13],[14],[15],[16],[17].
###end p 7
###begin p 8
###xml 145 149 145 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Trzcinski1">[18]</xref>
###xml 287 291 287 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Malley2">[19]</xref>
###xml 449 453 449 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-vanRossum1">[20]</xref>
###xml 552 556 552 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Trzcinski1">[18]</xref>
###xml 557 561 557 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Malley2">[19]</xref>
###xml 65 69 <span type="species:ncbi:10090">mice</span>
Surprisingly however, recent studies have shown that immunity in mice to pneumococcal colonization acquired from prior exposure to live bacteria [18] or a killed, whole-cell vaccine [WCV, consisting of killed pneumococcal whole cell antigen (WCA) with cholera toxin (CT) as an adjuvant] [19] is independent of antibodies of any specificity, and clearance of longstanding carriage in previously unexposed animals can likewise be antibody-independent [20]. Immunity had been shown to be dependent on the presence of CD4+ T cells at the time of challenge [18],[19], but the co-participation of specific immune factors other than antibody was not ruled out.
###end p 8
###begin p 9
###xml 274 282 274 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 370 374 <span type="species:ncbi:10090">mice</span>
###xml 463 468 <span type="species:ncbi:9606">human</span>
###xml 508 516 <span type="species:ncbi:9606">children</span>
###xml 655 660 <span type="species:ncbi:9606">human</span>
Here we show that intranasal immunization with the WCV confers protection against experimental pneumococcal colonization via the chemoattractant and neutrophil activating cytokine IL-17A, in a neutrophil-dependent fashion. Methods were devised to assay expression of IL-17A in vitro using peripheral blood samples. IL-17A expression by peripheral blood of WCV-immunized mice is highly correlated with subsequent protection against colonization, and expression by human cells, including those from adults and children, can be shown as well. Finally, we developed a surface phagocytosis assay with which we show that IL-17A enhances pneumococcal killing by human polymorphonuclear cells in the absence as well as presence of opsonins.
###end p 9
###begin p 10
###xml 157 165 157 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 118 124 <span type="species:ncbi:9606">humans</span>
The data indicate the possibility that IL-17A responses play a role in naturally-acquired immunity to pneumococcus in humans and that assay of this cytokine in vitro may assist in the evaluation of certain candidate pneumococcal vaccines that target mucosal colonization.
###end p 10
###begin title 11
Results
###end title 11
###begin title 12
###xml 18 22 <span type="species:ncbi:10090">mice</span>
Prior exposure of mice to killed or live pneumococci reduces the duration of experimental pneumococcal carriage
###end title 12
###begin p 13
###xml 659 668 659 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000159-g001">Figure 1A</xref>
###xml 876 885 876 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000159-g001">Figure 1A</xref>
###xml 156 160 <span type="species:ncbi:10090">mice</span>
###xml 228 232 <span type="species:ncbi:10090">mice</span>
###xml 439 443 <span type="species:ncbi:10090">mice</span>
###xml 556 560 <span type="species:ncbi:10090">mice</span>
###xml 602 606 <span type="species:ncbi:10090">mice</span>
###xml 710 714 <span type="species:ncbi:10090">mice</span>
###xml 943 947 <span type="species:ncbi:10090">mice</span>
###xml 953 957 <span type="species:ncbi:10090">mice</span>
###xml 1124 1128 <span type="species:ncbi:10090">mice</span>
The duration of carriage was followed after intranasal challenge with serotype 6B pneumococci 4 weeks post-exposure to WCV. Both WCV-vaccinated and control mice immunized with CT alone were colonized one day after challenge. In mice immunized with WCV however, carriage became significantly reduced after 4 days compared to controls given cholera toxin (CT) adjuvant alone (median density of colonization on day 4 in WCV- vs. CT-immunized mice 251 vs. 3720 cfu/nasal wash, P = 0.029 by Mann-Whitney U test) and was undetectable by day 6 (0/4 WCV-immunized mice had detectable colonies on day 6 vs. 4/4 mice that received CT, P = 0.029 by Fisher's Exact test, Figure 1A). A similar differential was observed in mice that had been repeatedly exposed to live pneumococci vs. saline controls: the density of colonization became significantly different by day 4 after inoculation (Figure 1A). By day 6, similar to what we observed in WCV-immunized mice, 0/4 mice exposed to live pneumococci had detectable colonies compared to 4/4 saline controls (P = 0.029 by Fisher's exact test). When data from all time points were compared, mice immunized with WCV or exposed to live pneumococci had a significantly shorter time to clearance compared to their respective CT or saline controls (P = 0.0001 for comparison of WCV vs. CT and P = 0.004 for comparison of live exposure vs. saline). Thus the protection by prior pneumococcal exposure involves not immediate blockage of colonization but rather an accelerated clearance over days. Subsequent studies compared WCV-vaccinated with control animals 7 days after the intranasal challenge.
###end p 13
###begin title 14
Duration of carriage and effect of adoptive transfer following immunization with killed or live pneumococci.
###end title 14
###begin p 15
###xml 745 748 745 748 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1235 1238 1235 1238 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1328 1331 1328 1331 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 116 120 <span type="species:ncbi:10090">mice</span>
###xml 149 153 <span type="species:ncbi:10090">mice</span>
###xml 406 410 <span type="species:ncbi:10090">mice</span>
###xml 474 478 <span type="species:ncbi:10090">mice</span>
###xml 681 685 <span type="species:ncbi:10090">mice</span>
###xml 749 753 <span type="species:ncbi:10090">mice</span>
###xml 853 858 <span type="species:ncbi:10090">mouse</span>
###xml 1053 1057 <span type="species:ncbi:10090">mice</span>
###xml 1190 1194 <span type="species:ncbi:10090">mice</span>
###xml 1239 1243 <span type="species:ncbi:10090">mice</span>
###xml 1264 1268 <span type="species:ncbi:10090">mice</span>
###xml 1332 1336 <span type="species:ncbi:10090">mice</span>
###xml 1383 1387 <span type="species:ncbi:10090">mice</span>
###xml 1441 1445 <span type="species:ncbi:10090">mice</span>
###xml 1484 1488 <span type="species:ncbi:10090">mice</span>
A. Effect of intranasal immunization with WCV or live exposure upon density of pneumococcal colonization in C57BL/6 mice. Density of colonization in mice immunized with WCV vs. CT alone or repeatedly exposed to live pneumococcal strain 0603 vs. saline alone at various time points (n = 4 per time point) following challenge. By day 4, both the incidence and density of carriage were significantly lower in mice immunized with WCV or exposed to live pneumococcus compared to mice immunized with CT or saline, respectively. * P<0.05. The dashed line represents the lower limit of detection of bacterial colonization. B. Effect of adoptive transfer of CD4+ T cells from WCV-immunized mice on pneumococcal colonization of recipient, unimmunized RAG1-/- mice. Each data point represents the density of nasopharyngeal colonization in cfu/ nasal wash for each mouse one week post-challenge. The horizontal bar shows the geometric mean cfu/nasal wash for each group and the dashed line represents the lower limit of detection of bacterial colonization. C57BL/6 mice were immunized with WCV or CT as indicated. Four weeks after the last immunization, CD4+ T cells were harvested from splenocytes of mice and infused into naive, unimmunized RAG1-/- mice; challenge of these mice and quantification of colonization was then performed. RAG1-/- mice that received CD4+ T cells from WCV-immunized mice had significantly lower density of colonization than mice that received cells from CT-immunized mice (*** P<0.0001 by Mann-Whitney U).
###end p 15
###begin title 16
###xml 76 79 76 79 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 80 84 <span type="species:ncbi:10090">mice</span>
CD4+ T cells transfer acquired immunity to pneumococcal colonization to RAG1-/- mice
###end title 16
###begin p 17
###xml 150 154 150 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Malley2">[19]</xref>
###xml 155 159 155 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-vanRossum1">[20]</xref>
###xml 160 164 160 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Malley3">[21]</xref>
###xml 165 169 165 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Basset1">[22]</xref>
###xml 325 328 325 328 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 444 447 444 447 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 681 690 681 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000159-g001">Figure 1B</xref>
###xml 87 91 <span type="species:ncbi:10090">mice</span>
###xml 329 333 <span type="species:ncbi:10090">mice</span>
###xml 399 403 <span type="species:ncbi:10090">mice</span>
###xml 448 452 <span type="species:ncbi:10090">mice</span>
###xml 509 513 <span type="species:ncbi:10090">mice</span>
###xml 585 589 <span type="species:ncbi:10090">mice</span>
###xml 621 625 <span type="species:ncbi:10090">mice</span>
Several previous studies showed that acquired immunity to pneumococcal colonization in mice can be antibody-independent and dependent on CD4+ T cells [19],[20],[21],[22]. Here, adoptive transfer showed that CD4+ T cells are not only necessary but also sufficient for the accelerated clearance induced by WCV: unimmunized Rag1-/- mice (lacking both B and T cells) were infused with CD4+ T cells from mice immunized with WCV or CT alone. The RAG1-/- mice that received CD4+ T cells from WCV-immunized wild-type mice had significantly reduced density of colonization by day 7 compared to mice infused with CD4+ T cells from mice immunized with CT alone (P = 0.0001 by Mann-Whitney U, Figure 1B).
###end p 17
###begin title 18
###xml 71 72 71 72 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
Acquired immunity to pneumococcal colonization is associated with the TH17 subset of CD4+ T cells
###end title 18
###begin p 19
###xml 529 538 515 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000159-g002">Figure 2A</xref>
###xml 698 707 684 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000159-g002">Figure 2A</xref>
###xml 122 126 <span type="species:ncbi:10090">mice</span>
###xml 196 200 <span type="species:ncbi:10090">mice</span>
###xml 315 319 <span type="species:ncbi:10090">mice</span>
###xml 442 446 <span type="species:ncbi:10090">mice</span>
###xml 554 558 <span type="species:ncbi:10090">mice</span>
###xml 665 669 <span type="species:ncbi:10090">mice</span>
###xml 749 753 <span type="species:ncbi:10090">mice</span>
###xml 889 893 <span type="species:ncbi:10090">mice</span>
###xml 978 982 <span type="species:ncbi:10090">mice</span>
To evaluate which CD4+ T cell subset is responsible for protection, IFN-gamma, IL-4 or IL-17A receptor (IL-17AR) knockout mice were immunized with WCV vs. CT alone. IFN- gamma- and IL-4-deficient mice immunized with WCV were significantly protected against colonization both with respect to proportion of colonized mice (P<0.001 by Fisher's Exact test for comparison of % of colonization in WCV- and CT-immunized IFN-gamma- or IL-4-deficient mice) and density of colonization (P</=0.001 compared to their respective CT controls, Figure 2A). In contrast, mice with a targeted deletion of the IL-17A receptor were not protected (P>0.5 vs. CT controls for % colonized mice or density of colonization, Figure 2A). It is noteworthy that IL-17AR-knockout mice in the CT control group had, on average, a ten-fold greater density of colonization than the corresponding IFN-gamma or IL-4 deficient mice, suggesting that IL-17A may also be involved in resistance to colonization in naive mice.
###end p 19
###begin title 20
Role of T-helper-subset-associated cytokines in protection from nasopharyngeal colonization.
###end title 20
###begin p 21
###xml 3 7 <span type="species:ncbi:10090">Mice</span>
###xml 132 136 <span type="species:ncbi:10090">Mice</span>
###xml 278 282 <span type="species:ncbi:10090">mice</span>
###xml 455 459 <span type="species:ncbi:10090">mice</span>
###xml 487 491 <span type="species:ncbi:10090">mice</span>
###xml 813 817 <span type="species:ncbi:10090">mice</span>
###xml 1001 1005 <span type="species:ncbi:10090">mice</span>
###xml 1489 1493 <span type="species:ncbi:10090">mice</span>
###xml 1526 1530 <span type="species:ncbi:10090">mice</span>
###xml 1885 1889 <span type="species:ncbi:10090">mice</span>
###xml 2112 2116 <span type="species:ncbi:10090">mice</span>
###xml 2192 2196 <span type="species:ncbi:10090">mice</span>
###xml 2224 2228 <span type="species:ncbi:10090">mice</span>
###xml 2527 2531 <span type="species:ncbi:10090">mice</span>
###xml 2591 2595 <span type="species:ncbi:10090">mice</span>
A. Mice defective in IFN-gamma, IL-4 or IL-17A receptor were immunized as described, then challenged with pneumococcal strain 0603. Mice with IFN-gamma or IL-4 deficiency were significantly protected by WCV (P<0.001 vs. respective CT controls) whereas IL-17A receptor deficient mice were not protected (P>0.5 vs. CT). Dashed line represents the lower limit of detection of bacterial colonization. B. Expression of IL-17A from splenocytes of WCV-immunized mice. Cultured splenocytes from mice immunized with WCV (black columns) or CT alone (white columns) were stimulated for 72 hours with medium alone, Concanavalin A (5 microg/ml), WCA (10 microg dry weight) after which IL-17A production was measured by ELISA. Significantly more IL-17A was expressed following WCA stimulation of WCV-immunized vs. CT-immunized mice, although response to concanavalin A was similar. C. Effect of CD4+ T cell depletion upon IL-17A expression from splenocytes. Splenocytes (without or with CD4+ T cell depletion) from mice immunized with WCV were stimulated for 72 hours with medium alone or WCA after which IL-17A was measured by ELISA. IL-17A expression in splenocytes following WCA stimulation was significantly higher in the presence of CD4+ T cells compared to stimulation with medium alone or when CD4+ T cells were depleted. Repletion of CD4+ T cells restored the response. ** P<0.01 compared to cells stimulated with medium alone. D. IL-17A intracellular staining of splenocytes from WCV immunized mice. Splenocytes from WCV immunized mice were stimulated with WCA, blocked with monensin, harvested and stained for CD4+ and intracellular IL-17A as described. There is a statistically significant increase in CD4+ IL-17A positive cells following stimulation with WCA, which is not observed in the CD4- population. No increase in IL-17A positive cells could be detected in cells from unimmunized mice (data not shown). **P = 0.008 for comparison of frequency of IL-17A-positive cells in absence and presence of WCA stimulation among CD4+ cells. Data shown here are representative of three experiments, including at least 5 mice per experiment. E. Expression of IL-17A from NALT of WCV- vs. CT-immunized mice. Cultured splenocytes from mice immunized with WCV (black columns) or CT alone (white columns) were stimulated for 72 hours with medium alone or with WCA (10 microg dry weight) after which IL-17A production was measured by ELISA. Significantly more IL-17A was expressed following WCA stimulation of WCV-immunized vs. CT-immunized mice. **P<0.01 for comparison of IL-17A in WCV vs. CT-immunized mice following stimulation with WCA.
###end p 21
###begin p 22
###xml 96 104 96 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 141 150 141 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000159-g002">Figure 2B</xref>
###xml 283 287 283 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Malley2">[19]</xref>
###xml 711 720 711 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000159-g002">Figure 2C</xref>
###xml 848 857 848 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000159-g002">Figure 2D</xref>
###xml 17 21 <span type="species:ncbi:10090">mice</span>
###xml 1326 1330 <span type="species:ncbi:10090">mice</span>
Splenocytes from mice immunized with WCV expressed significantly more IL-17A in response to WCA in vitro than cells from CT control animals (Figure 2B). We have previously shown that immunization with WCV confers protection against NP colonization in a CD4+ T cell dependent fashion [19]; additional experiments were performed here to confirm that IL-17A is produced by CD4+ T cells. Depletion of CD4+ T cells effectively abrogated IL-17A expression from WCA-stimulated splenocytes, such that there was no detectable increase in IL-17A production compared to splenocytes stimulated with medium alone; repletion of CD4+ T cells restored the IL-17A response seen with nondepleted splenocytes stimulated with WCA (Figure 2C). Moreover, intracellular cytokine staining experiments confirmed that IL-17A production originates primarily from CD4+ cells (Figure 2D). Splenocytes from WCV-immunized animals were stimulated with WCA and analyzed by flow cytometry. The frequency of IL-17A positive cells increased 2.3 fold among CD4+ T cells (3.37% in WCA stimulated cells vs. 1.49% in cells stimulated with medium alone, P = 0.008 by Mann-Whitney U) whereas the non-CD4+ population was unaffected (1.5% vs. 1.7% for stimulation with WCA vs. medium alone in CD4- cells, P = 0.5). Similar analyses were performed using splenocytes from mice immunized with CT alone; no increase in IL-17A positive cells was noted, either in the CD4+ or CD4- population (data not shown). Collectively, these results indicate that IL-17A is produced by CD4+ T cells.
###end p 22
###begin p 23
###xml 358 367 358 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000159-g002">Figure 2E</xref>
###xml 86 90 <span type="species:ncbi:10090">mice</span>
###xml 252 256 <span type="species:ncbi:10090">mice</span>
Next, we harvested nasal associated lymphoid tissue (NALT) from WCV- and CT-immunized mice. Cells were incubated for 3 days in the presence of medium alone or with WCA, after which IL-17A expression was measured by ELISA. NALT cells from WCV-immunized mice showed significantly greater IL-17A production than CT controls in response to stimulation with WCA (Figure 2E).
###end p 23
###begin p 24
###xml 292 300 284 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 378 386 370 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 639 647 629 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000159-g003">Figure 3</xref>
###xml 71 76 <span type="species:ncbi:10090">mouse</span>
###xml 105 109 <span type="species:ncbi:10090">mice</span>
###xml 657 661 <span type="species:ncbi:10090">mice</span>
To test whether the capacity to produce IL-17A predicted an individual mouse's protection, a total of 90 mice were intranasally immunized with CT (1 microg) plus a range of doses of WCA ranging from 1 to 100 microg and blood samples were taken 7 days before challenge and stimulated with WCA in vitro for IL-17A production. The IL-17A concentrations following 6 days of culture in vitro varied from undetectable (<0.02 ng/ml) to about 6 ng/ml, and the cfu of pneumococci/nasal wash 7 days post-challenge varied from undetectable (<1.6 cfu/nasal wash) to about 3000; there was a strong inverse correlation (Spearman rho = -0.62, P <0.0001, Figure 3); 95% of mice with pre-challenge IL-17A concentrations above 0.3 ng/ml were free of pneumococcal colonization.
###end p 24
###begin title 25
###xml 79 83 <span type="species:ncbi:10090">mice</span>
Correlation of IL-17A expression and density of nasopharyngeal colonization in mice.
###end title 25
###begin p 26
###xml 34 38 <span type="species:ncbi:10090">mice</span>
Three weeks after immunization of mice (n = 90) with CT with doses of WCA ranging from 1 to 100 microg, and one week before pneumococcal challenge, blood samples were obtained and stimulated with WCA (10 microg) for 6 days, after which supernatants were collected and assayed for IL-17A concentration. The correlation between density of colonization (cfu/nasal wash) 7 days after challenge and pre-challenge IL-17A expression was evaluated. IL-17A expression was significantly correlated with density of colonization.
###end p 26
###begin title 27
Neutrophil-like cells are required for acquired immunity to pneumococcal carriage
###end title 27
###begin p 28
###xml 62 66 62 66 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Kolls1">[23]</xref>
###xml 152 156 <span type="species:ncbi:10090">Mice</span>
###xml 699 703 <span type="species:ncbi:10090">mice</span>
###xml 832 836 <span type="species:ncbi:10090">mice</span>
###xml 883 887 <span type="species:ncbi:10090">mice</span>
###xml 966 970 <span type="species:ncbi:10090">mice</span>
###xml 1101 1105 <span type="species:ncbi:10090">mice</span>
###xml 1201 1205 <span type="species:ncbi:10090">mice</span>
Because IL-17 A induces neutrophil recruitment and activation [23], we evaluated whether neutrophils were required for protection against colonization. Mice intranasally immunized with WCV (or CT alone) were challenged, with or without administration of monoclonal antibody RB6-8C5 (which targets neutrophil-like cells) at the time of challenge. Several experiments were performed to ensure that treatment with this antibody did not affect CD4+ T cell number or function. Evaluation of splenocytes of antibody-treated animals showed no reduction in the CD4+ T cell population (data not shown). Furthermore, we confirmed that IL-17A production from the peripheral blood or from NALT of WCV-immunized mice was not affected by treatment with RB6-8C5 antibody. The peripheral blood IL-17A expression from immunized, neutrophil-depleted mice was similar to that of immunized, nondepleted mice (median IL-17A whole blood expression in neutrophil depleted vs. non-depleted mice: 1059 vs. 1290 pg/ml, P = 0.7 by Mann-Whitney U test); similarly, there was no reduction in NALT IL-17A expression from immunized mice following neutrophil depletion (median IL-17A expression from NALT in depleted vs. nondepleted mice 23.6 vs. 19.8 pg/ml, P = 0.69 by Mann-Whitney U test).
###end p 28
###begin p 29
###xml 74 83 74 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000159-g004">Figure 4A</xref>
###xml 781 790 779 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000159-g004">Figure 4B</xref>
###xml 124 128 <span type="species:ncbi:10090">mice</span>
###xml 169 173 <span type="species:ncbi:10090">mice</span>
###xml 199 203 <span type="species:ncbi:10090">mice</span>
###xml 259 263 <span type="species:ncbi:10090">mice</span>
###xml 475 479 <span type="species:ncbi:10090">mice</span>
###xml 525 529 <span type="species:ncbi:10090">mice</span>
###xml 742 746 <span type="species:ncbi:10090">mice</span>
Neutrophil depletion significantly diminished protection by immunization (Figure 4A). WCV-immunized and neutrophil depleted mice had both higher proportion of colonized mice (9/14 vs. 3/15 colonized mice for neutrophil-depleted vs. non-depleted WCV-immunized mice respectively, P = 0.025 by Fisher's Exact test) and density of colonization (median 12.8 cfu/nasal wash vs. 0.8 cfu/nasal wash respectively, P = 0.05 by Mann-Whitney U). While WCV-immunized, neutrophil-depleted mice had reduced colonization density compared to mice that received CT alone (median colonization density 453 cfu/nasal wash, P = 0.006 by Mann-Whitney U), the percentage of remaining neutrophils was strongly negatively correlated with recovered cfu from challenged mice (Spearman rho = -0.77, P = 0.001, Figure 4B), suggesting that residual protection was accounted for in large part by incomplete neutrophil depletion.
###end p 29
###begin title 30
Effect of neutrophils on WCV-induced protection against pneumococcal colonization.
###end title 30
###begin p 31
###xml 1197 1200 1197 1198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#961;</italic>
###xml 191 196 <span type="species:ncbi:10090">mouse</span>
###xml 354 358 <span type="species:ncbi:10090">Mice</span>
###xml 440 444 <span type="species:ncbi:10090">mice</span>
###xml 532 536 <span type="species:ncbi:10090">mice</span>
###xml 617 621 <span type="species:ncbi:10090">mice</span>
###xml 708 712 <span type="species:ncbi:10090">mice</span>
###xml 789 793 <span type="species:ncbi:10090">mice</span>
###xml 1341 1345 <span type="species:ncbi:10090">mice</span>
###xml 1387 1391 <span type="species:ncbi:10090">mice</span>
###xml 1696 1700 <span type="species:ncbi:10090">mice</span>
###xml 1773 1777 <span type="species:ncbi:10090">mice</span>
###xml 2001 2005 <span type="species:ncbi:10090">mice</span>
A. Effect of neutrophil depletion on WCV-induced protection from nasopharyngeal colonization. Each data point represents the density of nasopharyngeal colonization in cfu/nasal wash for each mouse. The horizontal bar shows the geometric mean cfu/nasal wash for each group and the dashed line shows the lower limit of detection of bacterial colonization. Mice were immunized with CT or WCV as indicated; just prior to the time of challenge, mice were randomized to receive antineutrophil antibody vs. saline. Proportion of colonized mice and density of colonization was determined 7 days post challenge. WCV-immunized mice that received saline treatment were significantly better protected than WCV-immunized mice that received antineutrophil antibody, with a lower proportion of colonized mice (P = 0.025 by Fisher's Exact) and density of colonization (P = 0.05 by Mann-Whitney U). B. Correlation between neutrophil count and density of pneumococcal colonization. Neutrophil counts following neutrophil depletion were assayed at the time of sacrifice and plotted against density of colonization. There was a strong negative association between neutrophil counts and colonization density (Spearman rho = -0.75). C. Histopathology of nasopharyngeal tissue following nasopharyngeal challenge of CT- (left panel) and WCV-immunized (right panel) mice. Seven days post pneumococcal challenge, mice were euthanized, heads stored in formalin, and H&E sections of nasopharyngeal tissue prepared and examined under light microscopy at 60x magnification. The presence of a dense neutrophilic infiltrate in the submucosa at the junction of the olfactory and respiratory epithelium was noted in WCV-immunized mice following pneumococcal nasopharyngeal challenge but not in CT-immunized mice. The two slides shown are representative of a total of 15 examined specimens (8 WCV-immunized and 7 CT controls, all at day 7 post pneumococcal challenge). Lesions like those represented here were observed in 6/8 immunized mice and 0/7 controls.
###end p 31
###begin p 32
###xml 280 302 280 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000159-g004">Figure 4C, right panel</xref>
###xml 110 114 <span type="species:ncbi:10090">mice</span>
###xml 438 442 <span type="species:ncbi:10090">mice</span>
###xml 591 595 <span type="species:ncbi:10090">mice</span>
Consistent with these results, blinded review of histopathology of nasopharyngeal tissue of 6/8 WCV-immunized mice seven days after challenge with pneumococcus showed a distinct neutrophilic infiltrate in the submucosa at the junction of the olfactory and respiratory epithelium (Figure 4C, right panel), which is not seen in CT-immunized subsequently challenged with pneumococci (left panel) (presence of infiltrate in 6/8 WCV immunized mice vs. 0/7 CT controls, P = 0.007). Thus the data support a role for IL-17A acting upon neutrophils in protection against pneumococcal colonization in mice.
###end p 32
###begin title 33
###xml 21 26 <span type="species:ncbi:9606">human</span>
IL-17A expression in human samples following pneumococcal stimulation
###end title 33
###begin p 34
###xml 381 387 381 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000159-g005">Fig 5A</xref>
###xml 644 648 644 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Zhang1">[24]</xref>
###xml 830 838 830 838 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 840 846 840 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000159-g005">Fig 5B</xref>
###xml 81 87 <span type="species:ncbi:9606">humans</span>
###xml 506 512 <span type="species:ncbi:9606">humans</span>
###xml 520 524 <span type="species:ncbi:10090">mice</span>
###xml 720 725 <span type="species:ncbi:9606">human</span>
###xml 1011 1016 <span type="species:ncbi:9606">women</span>
###xml 1300 1305 <span type="species:ncbi:9606">women</span>
Next we determined whether IL-17A responses to pneumococcus could be measured in humans. Tonsillar mononuclear cells (from 8 donors) were stimulated with medium alone, WCA obtained from a pneumolysin-negative strain (WCA(ply-)) or WCA from the wild-type strain. IL-17A expression measured at 72 hours was significantly higher following stimulation with WCA than with medium alone (Fig 5A); this increase was abrogated when a pneumolysin-negative WCA was used as stimulus, consistent with prior findings in humans and in mice regarding the association between T cell-mediated responses to this toxin and prevention of pneumococcal colonization ([24] and unpublished data). Furthermore, whole blood from unimmunized adult human volunteers, presumed to have been naturally exposed to pneumococcus, produced IL-17A in response to WCA in vitro (Fig 5B). Eighteen subjects produced a range of IL-17A concentrations from about 4 to 200 pg/ml, with a geometric mean of 20 pg/ml. Of these volunteers, 11 were parturient women, whose geometric mean IL-17A expression was 18 pg/ml. Umbilical cord blood was available in each of these cases; IL-17A in these samples was at the lower limit of detection of the assay (4 pg/ml) in all but one case, significantly lower than that of all adult subjects or parturient women (P<0.001 and P<0.01, respectively by Mann-Whitney U).
###end p 34
###begin title 35
###xml 61 66 <span type="species:ncbi:9606">human</span>
Effect of exposure to pneumococcus on IL-17A expression from human tissues and cells.
###end title 35
###begin p 36
###xml 62 70 <span type="species:ncbi:9606">children</span>
###xml 615 620 <span type="species:ncbi:9606">women</span>
A. Expression of IL-17A from tonsillar mononuclear cells from children. Tonsillar cells (n = 8) were cultured as described and stimulated with WCA or WCA derived from an isogenic, pneumolysin-negative strain (WCAply-). Stimulation with WCA was associated with significantly increased IL-17A expression compared to exposure to medium alone (P = 0.008 by Wilcoxon signed rank test), whereas stimulation with WCAply- did not increase IL-17A production. B. Expression of IL-17A from peripheral blood of adults and umbilical cord blood. Peripheral blood samples from adults (healthy adult volunteers (n = 7), parturient women (n = 11) and umbilical cord blood (n = 11) were stimulated with WCA for 6 days after which IL-17A concentration was assayed by ELISA. IL-17A production was significantly greater in adults than cord blood (P<0.001 by Mann-Whitney U test).
###end p 36
###begin title 37
IL-17A enhances in vitro phagocytic killing of pneumococci
###end title 37
###begin p 38
###xml 37 45 37 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 795 804 795 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000159-g006">Figure 6B</xref>
###xml 893 902 893 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000159-g006">Figure 6A</xref>
###xml 929 937 929 937 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 72 77 <span type="species:ncbi:9606">human</span>
###xml 188 192 <span type="species:ncbi:10090">mice</span>
###xml 403 408 <span type="species:ncbi:9606">human</span>
We evaluated whether IL-17A enhances in vitro killing of pneumococci by human neutrophils in different assays. Having reported previously that WCV induced protection in antibody-deficient mice, we developed a surface phagocytic killing assay to evaluate whether -17A could potentiate killing of non-opsonized pneumococci. Neutrophils isolated from healthy volunteers were pre-incubated with recombinant human IL-17A, then overlaid on pneumococci that had been plated onto blood agar. The overlay of IL-17A in the absence of neutrophils did not result in any killing, consistent with studies in which the addition of IL-17A to culture medium did not affect growth of pneumococci and arguing against any direct killing effect of the cytokine or contaminant present in the preparation (as shown in Figure 6B). In the presence of neutrophils, IL-17A induced dose-dependent killing of pneumococci (Figure 6A). Thus IL-17A potentiated in vitro neutrophil killing of pneumococcus, in the absence of antibodies or complement.
###end p 38
###begin title 39
###xml 36 49 36 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 36 49 <span type="species:ncbi:1313">S. pneumoniae</span>
IL-17A-mediated enhanced killing of S. pneumoniae.
###end title 39
###begin p 40
###xml 65 78 65 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 367 368 361 362 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 439 452 433 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 783 796 773 786 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 19 24 <span type="species:ncbi:9606">human</span>
###xml 65 78 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 166 171 <span type="species:ncbi:9606">human</span>
###xml 439 452 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 739 744 <span type="species:ncbi:9606">human</span>
###xml 783 796 <span type="species:ncbi:1313">S. pneumoniae</span>
A and B. Effect of human IL-17A on surface phagocytic killing of S. pneumoniae. A. Isolated neutrophils from healthy adult volunteers were incubated with recombinant human IL-17A at the indicated concentrations and evaluated in a surface phagocytic killing assay with pneumococcal strain 0603; colonies were counted after overnight incubation at 37degreesC with 5% CO2. IL-17A induces a dose-dependent enhancement of neutrophil killing of S. pneumoniae (P = 0.01 for 1 or 10 microg of IL-17A vs. no added IL-17A). B. Supernatant obtained from neutrophils after incubation with IL-17A did not have any demonstrable antipneumococcal effect, whereas washed neutrophils after incubation with IL-17A demonstrated enhanced killing. C. Effect of human IL-17A on opsonophagocytic killing of S. pneumoniae. Neutrophils purified from the peripheral blood of healthy adult volunteers were incubated with pneumococci anticapsular antibodies, complement, and a range of concentrations of IL-17A as indicated for 90 minutes, following which viable counts were obtained by plating on blood agar plates. Each line represents a different volunteer. IL-17A enhanced killing of pneumococci in a dose-dependent fashion in 6/6 subjects. *P = 0.016 by Wilcoxon matched pairs test.
###end p 40
###begin p 41
###xml 668 677 664 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000159-g006">Figure 6B</xref>
To evaluate whether the potentiating effect of IL-17A is the result of lysis or degranulation of neutrophils, we performed trypan blue exclusion studies of neutrophils with and without preincubation with IL-17A at the highest dose studied (10 microg/ml). There was no difference in viability when IL-17A was added; over 95% of cells remained viable after 30 minutes of incubation. Furthermore, neutrophils preincubated with IL-17A then washed showed the same enhancement of pneumococcal killing as incubated neutrophils that were not washed. In contrast, the supernatant obtained after incubation of neutrophils and IL-17A had no detectable antipneumococcal activity (Figure 6B). Taken together, these data argue against a toxic or degranulating effect of IL-17A on neutrophils and are more consistent with enhancement of phagocytic activity of neutrophils by this cytokine.
###end p 41
###begin p 42
###xml 101 104 101 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Lipsitch1">[6]</xref>
###xml 105 109 105 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Rapola2">[25]</xref>
###xml 110 114 110 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Laine1">[26]</xref>
###xml 194 207 194 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 421 425 421 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Siber1">[27]</xref>
###xml 713 722 713 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000159-g006">Figure 6C</xref>
###xml 1135 1143 1127 1135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 92 100 <span type="species:ncbi:9606">children</span>
###xml 194 207 <span type="species:ncbi:1313">S. pneumoniae</span>
Because capsular and noncapsular antipneumococcal antibodies gradually increase with age in children [6],[25],[26], we also evaluated whether IL-17A would potentiate opsonophagocytic killing of S. pneumoniae in the presence of limiting amounts of antibody. Bacterial polysaccharide immune globulin (BPIG) is a plasma concentrate from volunteers immunized with bacterial polysaccharides including pneumococcal serotype 6B [27]. To evaluate whether IL-17A would synergize with antipneumococcal antibodies, we added IL-17A to an opsonophagocytic assay using a suboptimal dose of BPIG. When IL-17A was added to the reaction, killing of pneumococcus was enhanced in a dose-dependent fashion in all individuals tested (Figure 6C). Killing was significantly increased when either 1 microg or 10 microg/ml IL-17A were added (P = 0.016 by Wilcoxon matched pairs test). There was no significant pneumococcal killing in the assay in the absence of any of the principal components, including PMNs, antibody (BPIG) or complement (data not shown). Additionally, as in the surface phagocytosis assay, IL-17A alone had no effect on growth of bacteria in vitro or survival in our assay, implying that direct killing of pneumococci by IL-17A is very unlikely.
###end p 42
###begin title 43
Discussion
###end title 43
###begin p 44
###xml 251 277 251 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 281 302 281 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pneumocystis jiroveci</italic>
###xml 380 384 380 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Hoover1">[28]</xref>
###xml 385 389 385 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Phair1">[29]</xref>
###xml 395 408 395 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 524 528 524 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Gilks1">[30]</xref>
###xml 529 533 529 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Dworkin1">[31]</xref>
###xml 716 720 716 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Gill1">[32]</xref>
###xml 982 986 982 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Takahashi1">[33]</xref>
###xml 1011 1015 1011 1015 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Titanji1">[34]</xref>
###xml 1061 1065 1061 1065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Gordon1">[35]</xref>
###xml 1191 1192 1191 1192 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 120 123 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 251 277 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 281 302 <span type="species:ncbi:42068">Pneumocystis jiroveci</span>
###xml 395 408 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 410 413 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 599 602 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The importance of CD4+ T cells in protection against pulmonary infections became clearly evident with the advent of the HIV epidemic. Infected individuals have a dramatically increased risk of infections with opportunistic pulmonary pathogens such as Mycobacterium tuberculosis or Pneumocystis jiroveci and this risk is inversely related to the number of circulating CD4+ T cells [28],[29]. For S. pneumoniae, HIV infection confers a 50-fold increased risk of infection, which is also inversely related to CD4+ T cell count [30],[31]. Most recently, a study in Zambian mothers has demonstrated that HIV infection is associated with a significantly increased risk of colonization and reduced time to new colonization [32]. Various hypotheses have been advanced to explain why CD4+ T cell-deficiency is associated with such a high risk of infection with pneumococcus, a primarily extracellular encapsulated bacterium; these include reduced opsonic activity of anticapsular antibodies [33], loss of memory B cells [34], and alteration of innate pulmonary immunity [35]. To date, however, it is fair to state that the paradox remains unexplained. The data presented here suggest that a loss of TH17 cells may also contribute to this increased susceptibility.
###end p 44
###begin p 45
###xml 474 477 474 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Goldblatt1">[4]</xref>
###xml 478 482 478 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Gray1">[36]</xref>
###xml 483 487 483 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Musher1">[37]</xref>
###xml 488 492 488 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Dagan3">[38]</xref>
###xml 756 759 756 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Goldblatt1">[4]</xref>
###xml 961 964 961 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Weinberger1">[5]</xref>
###xml 1125 1128 1125 1128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Goldblatt1">[4]</xref>
###xml 1414 1420 1414 1420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">higher</italic>
###xml 1507 1511 1507 1511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Malley1">[11]</xref>
###xml 1630 1637 1630 1637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">greater</italic>
###xml 1873 1877 1873 1877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-McCool3">[39]</xref>
###xml 1775 1781 <span type="species:ncbi:9606">humans</span>
While the ability of pneumococcal conjugate vaccine-induced anticapsular antibodies to protect against pneumococcal colonization is clear, less is known about the natural development of immunity to pneumococcal colonization. There appear to be both antibody-dependent and antibody-independent mechanisms that reduce the likelihood or duration of carriage. Several studies have documented a homotypic anticapsular serum antibody response to colonizing pneumococcal serotypes [4],[36],[37],[38]. In a longitudinal study examining the relationship between antibodies and carriage in adults, Goldblatt et al. showed that, among six serotypes tested, anticapsular antibody concentration to serotype 14 was significantly associated with reduced odds of carriage [4]. More recently, by analyzing longitudinal carriage data from Israeli toddlers in daycare, we found a lower risk of colonization with type 6A, 14, and 23F after previous exposure to the homologous type [5]. For types 14 and 23F, this specific protection correlated with increased serotype-specific antibody concentration. On the other hand, as in the previous study [4], there was no evidence for such a correlation with several other serotypes. Several studies have argued against the role of anticapsular antibody. For example, the risk of acquisition of new pneumococcal strains in adults with chronic obstructive pulmonary disease was associated with higher preacquisition concentrations of anticapsular and noncapsular pneumococcal antibodies [11]. These results suggest that in this population, antipneumococcal antibodies are markers of prior exposure and perhaps greater susceptibility rather than predictors of protection. Finally, in the sole published example of experimental pneumococcal colonization of humans, antibodies to the capsular polysaccharide did not predict protection against colonization [39].
###end p 45
###begin p 46
###xml 152 156 152 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Trzcinski1">[18]</xref>
###xml 157 161 157 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Malley2">[19]</xref>
###xml 162 166 162 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-vanRossum1">[20]</xref>
###xml 167 171 167 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Basset1">[22]</xref>
###xml 172 176 172 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Trzcinski2">[40]</xref>
###xml 379 383 379 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Malley3">[21]</xref>
###xml 567 571 567 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Zhang1">[24]</xref>
###xml 707 708 707 708 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 818 822 818 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Basset1">[22]</xref>
###xml 890 891 890 891 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 1034 1038 1030 1034 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-vanRossum1">[20]</xref>
###xml 1186 1187 1182 1183 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 1276 1280 1272 1276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Veldhoen1">[41]</xref>
###xml 1281 1285 1277 1281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Bettelli1">[42]</xref>
###xml 139 144 <span type="species:ncbi:10090">mouse</span>
###xml 558 566 <span type="species:ncbi:9606">children</span>
###xml 969 973 <span type="species:ncbi:10090">mice</span>
###xml 1029 1033 <span type="species:ncbi:10090">mice</span>
###xml 1130 1134 <span type="species:ncbi:10090">mice</span>
We, and others, have presented data supporting a role of CD4+ T cells, independently of antibody, in reducing pneumococcal colonization in mouse models [18],[19],[20],[22],[40]. In studies involving immunization with the pneumococcal zwitterionic conserved cell wall polysaccharide, we showed that neutralization of IL-17A significantly reduced protection, albeit not completely [21]. Zhang et al. then showed that reduced CD4+ T cell proliferative responses to the pneumococcal toxin pneumolysin were associated with nasopharyngeal pneumococcal carriage in children [24]. We subsequently showed that immunization with a mixture of a pneumolysin nontoxic mutant and two other pneumococcal proteins elicits TH17 cells and confers protection against colonization in a CD4+ T cell-dependent, antibody-independent fashion [22]. Others have argued against this possibility, proposing instead a TH1, IFN-gamma mediated mechanism, based on the finding that IL-12p40-deficient mice cleared pneumococcal colonization as well as wild-type mice [20]. Since that report, it has become clear that IL-23, which is lacking in IL-12p40 deficient mice, is not absolutely required for the generation of TH17 cells as once was thought, but instead participates in their maintenance or expansion [41],[42].
###end p 46
###begin p 47
###xml 45 46 45 46 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 109 122 109 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 200 203 200 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Hogberg1">[7]</xref>
###xml 257 258 257 258 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 264 265 264 265 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 623 645 619 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae in vitro</italic>
###xml 109 122 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 549 554 <span type="species:ncbi:9606">human</span>
###xml 623 636 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 754 762 <span type="species:ncbi:9606">children</span>
Here we present evidence that acquired CD4+ TH17 cells reduce the duration of experimental colonization with S. pneumoniae in a manner reminiscent of the age-dependent decline in duration of carriage [7] and that this mechanism occurs independently of key TH1 or TH2 cytokines, IFN- gamma and IL-4 respectively. We show that CD4+ T cells are sufficient to provide the protection against colonization, which is abrogated in the absence of the IL-17A receptor and highly dependent on neutrophils, one of the main targets of this cytokine. Recombinant human IL-17A enhances both antibody-independent and -dependent killing of S. pneumoniae in vitro. Importantly, IL-17A expression can be induced by exposure to pneumococcal antigens of tonsillar cells from children and peripheral blood from healthy adult volunteers, but not in umbilical cord blood, consistent with the view that this responsiveness may be the result of prior exposure to the pathogen.
###end p 47
###begin p 48
###xml 100 110 100 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Klebsiella</italic>
###xml 115 122 115 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Candida</italic>
###xml 137 141 137 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Ye1">[43]</xref>
###xml 142 146 142 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Huang1">[44]</xref>
###xml 219 220 219 220 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 366 387 366 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bordetella pertusssis</italic>
###xml 423 424 423 424 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 557 572 557 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 572 576 572 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Higgins1">[45]</xref>
###xml 577 581 577 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Khader1">[46]</xref>
###xml 582 586 582 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Khader2">[47]</xref>
###xml 700 701 700 701 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 132 136 <span type="species:ncbi:10090">mice</span>
###xml 557 572 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 615 620 <span type="species:ncbi:10090">mouse</span>
###xml 625 630 <span type="species:ncbi:9606">human</span>
IL-17A signaling been shown to participate in host defense against extracellular pathogens, such as Klebsiella and Candida in naive mice [43],[44]. Prior to this report, there have been two demonstrations of a role of TH17 cells in vaccine-induced immunity and in both cases, whole organisms, killed or live, were used. Higgins et al. showed that protection against Bordetella pertusssis with a whole cell vaccine induced TH17-dependent protection and Khader et al. presented similar findings with the mycobacterial protein ESAT6-induced protection against M. tuberculosis[45],[46],[47]. The data derived from both mouse and human studies in the present report thus add to the growing evidence that TH17 cells contribute to immunity to respiratory pathogens.
###end p 48
###begin p 49
###xml 188 191 188 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Goldblatt1">[4]</xref>
###xml 192 196 192 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Simell1">[15]</xref>
###xml 197 201 197 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Simell3">[48]</xref>
###xml 316 320 316 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Simell3">[48]</xref>
###xml 891 895 891 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Zhang1">[24]</xref>
###xml 416 420 <span type="species:ncbi:10090">mice</span>
###xml 573 579 <span type="species:ncbi:9606">humans</span>
Numerous attempts have been made to define correlates of protection against pneumococcal carriage and have focused on the humoral response to pneumococcal capsular or noncapsular antigens [4],[15],[48]; although associations between levels of antibodies in saliva and reduced risk of otitis media have been reported [48], no reliable correlate has been identified. Here we show that the IL-17A response in immunized mice is highly correlated with reduced carriage; in particular above a certain concentration, colonization beyond 7 days is very unlikely. Naturally-exposed humans have low, but measurable IL-17A responses, which could be evaluated in response to immunization with candidate pneumococcal vaccines, such as the whole cell vaccine currently under development. The demonstrated association between carriage and reduced T cell proliferative responses to pneumolysin in childhood [24] provides further support for a functional T cell assay such as the one proposed here.
###end p 49
###begin title 50
Materials and Methods
###end title 50
###begin title 51
Bacterial strains and immunogens
###end title 51
###begin p 52
###xml 0 13 0 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 59 63 59 63 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Malley4">[49]</xref>
###xml 126 127 114 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 308 312 292 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Malley4">[49]</xref>
###xml 456 460 440 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Trzcinski1">[18]</xref>
###xml 0 13 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 803 807 <span type="species:ncbi:10090">mice</span>
S. pneumoniae strain 0603 is a serotype 6B clinical strain [49]. Frozen mid-log phase aliquots were diluted to approximately106 cfu/10 microl of intranasal inoculum for challenge. The whole cell antigen (WCA) was derived from strain Rx1AL-, a capsule- and autolysin-negative mutant and prepared as described [49]. A pneumolysin-negative WCA (WCA(ply-)) was derived from an isogenic, pneumolysin-negative strain of Rx1AL- using methods previously described [18]. The final vaccine mixture (whole cell antigen WCA + adjuvant CT) for routine immunization contained 100 microg (dry weight) of WCA plus 1 microg of CT (List Biological Laboratories, Campbell, CA) per 10 microl dose. For potency comparisons, lower amounts of WCA were used (ranging from 0.1 microg to 10 microg). For all experiments, control mice were immunized nasally with 1 microg of CT in 10 microl saline.
###end p 52
###begin title 53
Animal models
###end title 53
###begin p 54
###xml 73 77 73 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Malley4">[49]</xref>
###xml 476 477 460 461 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 555 556 539 540 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 88 92 <span type="species:ncbi:10090">mice</span>
###xml 349 353 <span type="species:ncbi:10090">mice</span>
###xml 422 426 <span type="species:ncbi:10090">mice</span>
###xml 529 533 <span type="species:ncbi:10090">mice</span>
###xml 844 848 <span type="species:ncbi:10090">mice</span>
The animal model used in these experiments has been previously described [49]. C57BL/6J mice or mutants in the same background (female, age 6 weeks, Jackson Laboratories, Bar Harbor, ME) were randomized to receive 10 microl of whole cell vaccine or adjuvant alone intranasally twice at one week interval. Three weeks following the last inoculation, mice were anesthetized for retro-orbital blood sampling. One week later, mice were challenged intranasally with approximately106 cfu of strain 0603. At 1 week after challenge, the mice were euthanized by CO2 inhalation; an upper respiratory wash was done by instilling sterile, nonbacteriostatic saline retrograde through the transected trachea and collecting the first 6 drops (about 0.1 ml) from the nostrils. Following collection of nasopharyngeal samples, the heads of WCV- and CT-immunized mice were removed and placed in formalin prior to histopathological preparation with hematoxylin and eosin (H&E) staining.
###end p 54
###begin p 55
###xml 556 557 556 557 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 614 617 614 617 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 637 643 637 643 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm1Mom</sup>
###xml 77 81 <span type="species:ncbi:10090">mice</span>
###xml 355 359 <span type="species:ncbi:10090">mice</span>
###xml 618 622 <span type="species:ncbi:10090">mice</span>
###xml 702 706 <span type="species:ncbi:10090">mice</span>
To evaluate the time to eradication of carriage, in a separate experiment, 4 mice from groups of 16 each were sacrificed at 1, 2, 4 and 6 days post inoculation and sequential dilutions of nasal washes were plated. To test whether CD4+ T cells are sufficient for protection, adoptive transfer experiments were performed. Splenocytes from wild type C57Bl/6 mice immunized with WCV or CT alone were harvested 2 months after the last immunization and CD4+ T cells were purified by magnetic bead positive selection (Miltenyi Biotec, Auburn, CA). A total of 3x106 CD4+ T cells were injected retro-orbitally in naive RAG1-/- mice (B6.129S7-Rag1tm1Mom/J) that lack both B and T cells. The following day, these mice were challenged intranasally with strain 0603; one week later, density of colonization was determined as described above.
###end p 55
###begin p 56
###xml 136 141 132 137 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm1Ts</sup>
###xml 201 207 197 203 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm1Cgn</sup>
###xml 269 272 265 268 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 272 276 268 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Ye2">[50]</xref>
###xml 64 68 <span type="species:ncbi:10090">mice</span>
###xml 366 370 <span type="species:ncbi:10090">mice</span>
###xml 451 455 <span type="species:ncbi:10090">mice</span>
###xml 615 618 <span type="species:ncbi:10116">rat</span>
###xml 624 629 <span type="species:ncbi:10090">mouse</span>
###xml 677 683 <span type="species:ncbi:10090">murine</span>
###xml 833 837 <span type="species:ncbi:10090">mice</span>
To determine which T cell subset is responsible for protection, mice in the C57BL/6 background and deficient in IFN-gamma (B6.129S7-Ifngtm1Ts/J, Jackson Laboratories, Bar Harbor, ME) IL-4 (B6.129P2-Il4tm1Cgn/J, Jackson Laboratories) or the IL-17 receptor (B6.129 IL17Ra-/-[50]) were immunized and challenged as described above. For neutrophil depletion experiments, mice were immunized as described above; on days -1, +1 and +4 relative to challenge, mice were injected intraperitoneally with 100 microg of antineutrophil monoclonal antibody RB6-8C5 (purified from myeloma cell line by Bio Express, Lebanon, NH), a rat anti-mouse IgG2b directed against Ly-6G on the surface of murine myeloid (and limited subpopulations of lymphoid) lineage cells; in pilot experiments, this regimen resulted in >90% depletion of neutrophils in most mice, although variability was observed. Because of this variability, peripheral neutrophil counts were determined at the time of euthanasia and correlated with the number of recovered pneumococci from that animal.
###end p 56
###begin title 57
Measurement of IL-17A secretion by splenocytes
###end title 57
###begin p 58
###xml 303 304 299 300 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 563 564 543 544 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 95 99 <span type="species:ncbi:10090">mice</span>
###xml 387 391 <span type="species:ncbi:9913">calf</span>
Cellular suspensions of splenocytes were obtained by passing spleens from immunized or control mice through a 70-microm cell strainer (BD Biosciences, Bedford, MA). After washing and removal of red blood cells by hemolysis, cells were plated into 24-well tissue culture plates at a concentration of 5x106 cells/well in 500 microl of DMEM/F12 with L-glutamine supplemented with 10% fetal calf-serum, 50 microM 2-mercaptoethanol (Sigma), and 10 microg/ml ciprofloxacin. Following 72-hour stimulation with concanavalin A (5 microg/ml, Sigma) or WCA (equivalent to 106 cfu/ml), supernatants were collected following centrifugation and stored at -80degreesC until analyzed by ELISA for IL-17A concentration (R&D Systems, Minneapolis, MN). Supernatants were analyzed in duplicate and read against a standard, following directions provided by the manufacturer.
###end p 58
###begin p 59
###xml 367 368 367 368 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 461 462 461 462 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
For CD4+ T cell depletion, splenocytes were harvested as described above. CD4+ T cells were depleted from half of each spleen by magnetic bead selection (Miltenyi Biotec, Auburn, CA) following instructions by the manufacturer. Flow cytometry confirmed removal of >95% CD4+ T cells (data not shown). Cells were seeded at the same concentration as described above (5x106 cells/well). In some cases, we repleted CD4+ T cells from depleted splenocytes, by adding 106 CD4+ T cells in the relevant wells.
###end p 59
###begin title 60
Intracellular staining for IL-17A
###end title 60
###begin p 61
Splenocytes were harvested, seeded, and stimulated with medium or WCA (10 microg/ml) as described above. Twenty-four later, monensin (BD GolgiStop, BD Biosciences) was added as per the manufacturer's instructions and cells were harvested 12 hours later. Cells were washed, stained with anti-CD4+ antibody (antiCD4+-PE, BD Biosciences) in the presence of Fc block, permeabilized with Perm/Wash buffer (BD Biosciences), and incubated with antimouse IL17A Alexa Fluor-647 (eBioscience) for 30 minutes. Intracellular cytokine staining for IL-17A was compared in CD4- or CD4+ cells in medium alone or following stimulation with WCA. Samples were analyzed on a Cytomation MoFlo (Beckman Coulter, Fullerton, CA), and results analyzed with Summit Version 4.3 (Dako, Fort Collins, CO).
###end p 61
###begin title 62
Measurement of IL-17A secretion by NALT
###end title 62
###begin p 63
###xml 64 68 64 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Wu1">[51]</xref>
###xml 599 600 587 588 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 46 50 <span type="species:ncbi:10090">mice</span>
###xml 70 74 <span type="species:ncbi:10090">Mice</span>
###xml 426 430 <span type="species:ncbi:9913">calf</span>
NALT was harvested from immunized and control mice as described [51]. Mice were euthanized humanely, bled via intracardiac puncture to avoid blood contamination, and placed on a dissection board. The mouth was opened wide to expose the palate, which was cut carefully, so that the strips of NALT could be easily peeled off. These strips of cells were collected in medium (DMEM/F12 with L-glutamine supplemented with 10% fetal calf-serum, 50 microM 2-mercaptoethanol (Sigma), and 10 microg/ml ciprofloxacin) on ice. Cells were passed through a 70 microm strainer as described above and plated at 3x105 cells/well in a 96-well tissue culture plate in a total volume of 100 microl. Cells were stimulated with medium with or without added WCA (10 microg/ml) for a total of 3 days, after which supernatants were collected and assayed for IL-17A concentration by ELISA as above.
###end p 63
###begin title 64
Measurement of IL-17A secretion by whole blood
###end title 64
###begin p 65
###xml 309 310 301 302 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 333 334 325 326 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 33 37 <span type="species:ncbi:10090">mice</span>
###xml 41 47 <span type="species:ncbi:9606">humans</span>
###xml 151 155 <span type="species:ncbi:9913">calf</span>
###xml 322 326 <span type="species:ncbi:10090">mice</span>
###xml 346 351 <span type="species:ncbi:9606">human</span>
###xml 457 461 <span type="species:ncbi:10090">mice</span>
###xml 471 476 <span type="species:ncbi:9606">human</span>
For whole blood assays, blood of mice or humans at a final concentration of 10% was incubated in DMEM/F12 with L-glutamine supplemented with 10% fetal calf-serum, 50 microM 2-mercaptoethanol (Sigma), and 10 microg/ml ciprofloxacin in the absence or presence of killed pneumococcal antigen (corresponding to 107 cfu/ml for mice and 106 cfu/ml for human samples). Supernatants were collected after 6 days and the concentration of IL-17A measured as above for mice and, for human samples, by IL-17A ELISA (eBioscience Inc, San Diego, CA).
###end p 65
###begin title 66
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human subjects and samples
###end title 66
###begin p 67
###xml 47 55 <span type="species:ncbi:9606">Children</span>
###xml 170 175 <span type="species:ncbi:9606">women</span>
###xml 278 286 <span type="species:ncbi:9606">Children</span>
###xml 415 423 <span type="species:ncbi:9606">children</span>
###xml 578 586 <span type="species:ncbi:9606">Children</span>
###xml 613 621 <span type="species:ncbi:9606">Patients</span>
For peripheral blood, samples were obtained at Children's Hospital Boston (for healthy adult volunteers) or from Cambridge Health Alliance, Cambridge, MA (for parturient women or umbilical cord) after written informed consent had been obtained. The studies were approved by the Children's Hospital Boston and Cambridge Health Alliance research ethics committees. For tonsillar specimens, tonsils were obtained from children who were 2 to 12 years old (median age, 5 years), were undergoing tonsillectomy for hypertrophy, and were otherwise healthy at Bristol Royal Hospital for Children, Bristol, United Kingdom. Patients who were immunized against pneumococcus previously, who had received antibiotics within 2 weeks of the operation or steroids, or who had an immunodeficiency or serious infection were excluded. The study was approved by the South Bristol local research ethics committee and written informed consent was obtained in all cases.
###end p 67
###begin title 68
Agar surface phagocytic killing without opsonins
###end title 68
###begin p 69
###xml 79 83 79 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Smith1">[52]</xref>
###xml 314 316 314 316 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 323 325 323 325 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 337 343 <span type="species:ncbi:9913">bovine</span>
###xml 431 436 <span type="species:ncbi:9606">human</span>
This assay approximates the "surface phagocytosis" described by Smith and Wood [52]. Neutrophils were isolated from heparinized blood by density gradient centrifugation (Histopaque, Sigma) following manufacturer's instructions. Neutrophils were washed extensively then resuspended in Hanks' Balanced Solution (+ Ca2+ and Mg2+) with 0.2% bovine serum albumin (Sigma), then co-incubated for 30 minutes at 37degreesC with recombinant human IL-17A (R&D Biosystems) at different concentrations. In some experiments, the cells were harvested by centrifugation and the supernatant collected, to examine whether the potentiating effect of IL-17A could be detected with the supernatant alone. Between 8-10 replicates of 10 microl of a bacterial suspension containing on average 100 cfu of strain 0603 were plated onto blood agar and the fluid allowed to adsorb into the agar for 15 min; 15 microl of the neutrophil suspension was overlaid and allowed to adsorb; the plates were incubated at 37degreesC with 5% C02 overnight after which colonies were counted.
###end p 69
###begin title 70
Phagocytic killing in suspension with suboptimal opsonization
###end title 70
###begin p 71
###xml 197 198 197 198 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 517 530 517 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 544 548 544 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Malley4">[49]</xref>
###xml 603 604 603 604 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 862 873 862 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Haemophilus</italic>
###xml 916 920 916 920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Siber1">[27]</xref>
###xml 517 530 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 1159 1165 <span type="species:ncbi:9986">rabbit</span>
###xml 1288 1293 <span type="species:ncbi:9606">human</span>
Neutrophils were isolated from whole blood as described above, washed twice with cold Hanks Balanced Salt Solution (HBSS-) (Mediatech, Herndon, VA), and resuspended to a final concentration of 6x106 cells/ml in cold HBSS containing calcium and magnesium (HBSS+) (Cellgro Mediatech, Herndon, VA) then held on ice until used. Cell counts were determined on a standard hemocytometer by counting viable cells (as determined by an absence of blue staining in the presence of Trypan Blue (Cellgro Mediatech, Herndon, VA)). S. pneumoniae (strain 0603 [49]) was diluted in HBSS+ to a final concentration of 5x104 bacteria/ml and incubated with antibodies to pneumococcal polysaccharide (Bacterial Polysaccharide Immune Globulin, BPIG-8, a kind gift of Dr. George Siber, consisting of concentrated IgG obtained from serum of adult volunteers immunized with pneumococcal, Haemophilus and meningococcal polysaccharide vaccines [27]) diluted in HBSS+. The reaction was incubated at 37degreesC for 15 minutes rotating at 200 RPM to promote bacterial opsonization. After bacterial opsonization, the opsonophagocytic killing reaction was initiated with the addition of baby rabbit complement (Pelfreez Biologicals, Rogers, AR) and neutrophils (ratio of 1:200 bacteria:cells) with or without recombinant human IL-17A (R&D Systems, Minneapolis, MN) at 0.01, 0.1 or 1 microg/ml. A 1:1600 dilution of BPIG was chosen to give sub-optimal bacterial killing (<50% killing when compared to the same conditions without BPIG) in the presence of complement and neutrophils. The opsonophagocytic killing assay was performed in a 96-well round-bottom plate (Thermo Fisher Scientific, Waltham, MA) at 37degreesC for 90 minutes rotating at 200 RPM. After incubation, the opsonophagocytic reaction was diluted two fold and aliquots of each reaction were plated on blood agar plates then incubated at 37degreesC with 5% CO2 overnight.
###end p 71
###begin title 72
Isolation and culture of tonsillar mononuclear cells
###end title 72
###begin p 73
###xml 70 74 70 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Zhang2">[53]</xref>
###xml 75 79 75 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Zhang3">[54]</xref>
###xml 192 193 192 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 315 321 <span type="species:ncbi:9913">bovine</span>
###xml 546 551 <span type="species:ncbi:9606">human</span>
Mononuclear cells were isolated by using methods described previously [53],[54]. Tonsillar MNC were washed in sterile phosphate-buffered saline (PBS) and resuspended at a concentration of 4x106 cells/ml in RPMI medium containing HEPES, 2 mM glutamine, 100 U/ml penicillin, 100 microg/ml streptomycin, and 10% fetal bovine serum (Sigma, Dorset, United Kingdom). Cells were cultured in 96-well culture plates (Corning Inc, Corning, NY), and cell culture supernatants were collected at predetermined times and stored at -70degreesC until assays for human IL-17A were performed by sandwich ELISA (R&D Biosystems).
###end p 73
###begin title 74
Statistical analysis
###end title 74
###begin p 75
###xml 135 136 135 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</italic>
###xml 259 260 259 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</italic>
###xml 262 263 262 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</italic>
###xml 342 343 342 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 346 347 346 347 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 345 347 345 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p<sub>i</sub></italic>
###xml 348 349 348 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 418 422 418 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000159-Robertson1">[55]</xref>
###xml 493 494 493 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 527 528 527 528 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 526 528 526 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q<sub>i</sub></italic>
###xml 529 530 529 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 950 951 950 951 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 97 101 <span type="species:ncbi:10090">mice</span>
###xml 310 314 <span type="species:ncbi:10090">mice</span>
###xml 771 775 <span type="species:ncbi:10090">mice</span>
###xml 823 827 <span type="species:ncbi:10090">mice</span>
Incidence of carriage was compared by Fisher's exact test and colonization density in challenged mice was compared by the Mann-Whitney U test. Statistical significance of the difference between time-to-clearance curves was assessed as follows. For each group i (i = WCV, CT, live, or naive), the proportion of mice cleared at each time point t, pi(t), was calculated. Using the max-min formula for isotonic regression [55], these proportions were smoothed to assure they were nondecreasing in t, yielding smoothed proportions qi(t). Then, a test statistic was calculated to quantify the distance between the smoothed curves for two groups (e.g., WCV vs. CT): . The significance level of this test statistic was estimated by permuting the group identifiers of the cleared mice at each time point, fixing the total number of mice in each group and the total number cleared at each time point. 100,000 replicates of the permuted data were obtained, and T was calculated for each. The p value was calculated as the fraction of these 100,000 permutations having a test statistic strictly less than that calculated for the data. The correlation between neutrophil count or IL-17A concentration and colonization density was determined by Spearman rank correlation. The effect of increasing IL-17A concentrations on enhancing killing of pneumococcus was assessed by Wilcoxon matched pairs test. For all comparisons, P<0.05 was considered to represent a significant difference.
###end p 75
###begin p 76
The authors thank Michael Wessels for helpful discussions, Jay Mizgerd and Bryanne Robson for their assistance with neutrophil depletion studies, Rod Bronson for assistance with histopathological studies, Eric Tchetgen for statistical advice, Jessica Hartman Jacobs for programming assistance and Elizabeth Boush for advice and assistance with flow cytometry.
###end p 76
###begin title 77
References
###end title 77
###begin article-title 78
###xml 85 93 <span type="species:ncbi:9606">children</span>
Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group [In Process Citation].
###end article-title 78
###begin article-title 79
###xml 40 64 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers.
###end article-title 79
###begin article-title 80
###xml 49 73 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
Antibody responses to nasopharyngeal carriage of Streptococcus pneumoniae in adults: a longitudinal household study.
###end article-title 80
###begin article-title 81
Epidemiologic Evidence for Serotype-Specific Acquired Immunity to Pneumococcal Carriage.
###end article-title 81
###begin article-title 82
Age-specific incidence of invasive pneumococcal disease by serotype: Are anticapsular antibodies the primary mechanism of protection against invasive disease?
###end article-title 82
###begin article-title 83
Age- and serogroup-related differences in observed durations of nasopharyngeal carriage of penicillin-resistant pneumococci.
###end article-title 83
###begin article-title 84
Changing the Ecology of Pneumococci with Antibiotics and Vaccines.
###end article-title 84
###begin article-title 85
###xml 82 87 <span type="species:ncbi:9606">human</span>
Serum immunoglobulin G response to candidate vaccine antigens during experimental human pneumococcal colonization.
###end article-title 85
###begin article-title 86
###xml 41 65 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
###xml 71 77 <span type="species:ncbi:10090">Murine</span>
Limited Role of Antibody in Clearance of Streptococcus pneumoniae in a Murine Model of Colonization.
###end article-title 86
###begin article-title 87
Serum antipneumococcal antibodies and pneumococcal colonization in adults with chronic obstructive pulmonary disease.
###end article-title 87
###begin article-title 88
###xml 104 110 <span type="species:ncbi:10090">murine</span>
###xml 145 169 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae.
###end article-title 88
###begin article-title 89
###xml 16 20 <span type="species:ncbi:10090">mice</span>
###xml 125 149 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
Immunization of mice with combinations of pneumococcal virulence proteins elicits enhanced protection against challenge with Streptococcus pneumoniae.
###end article-title 89
###begin article-title 90
The potential to use PspA and other pneumococcal proteins to elicit protection against pneumococcal infection.
###end article-title 90
###begin article-title 91
Serum antibodies to pneumococcal neuraminidase NanA in relation to pneumococcal carriage and acute otitis media.
###end article-title 91
###begin article-title 92
Anti-PsaA and the risk of pneumococcal AOM and carriage.
###end article-title 92
###begin article-title 93
###xml 152 160 <span type="species:ncbi:9606">children</span>
Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal surface adhesin a, pneumolysin, and pneumococcal surface protein a in children.
###end article-title 93
###begin article-title 94
###xml 164 169 <span type="species:ncbi:10090">mouse</span>
Antibodies to conserved pneumococcal antigens correlate with, but are not required for, protection against pneumococcal colonization induced by prior exposure in a mouse model.
###end article-title 94
###begin article-title 95
CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization.
###end article-title 95
###begin article-title 96
###xml 76 100 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
###xml 106 112 <span type="species:ncbi:10090">murine</span>
Host and bacterial factors contributing to the clearance of colonization by Streptococcus pneumoniae in a murine model.
###end article-title 96
###begin article-title 97
###xml 90 94 <span type="species:ncbi:10090">mice</span>
Antibody-independent, interleukin-17A-mediated, cross-serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide.
###end article-title 97
###begin article-title 98
Antibody-independent, CD4+ T-cell-dependent protection against pneumococcal colonization elicited by intranasal immunization with purified pneumococcal proteins.
###end article-title 98
###begin article-title 99
Interleukin-17 family members and inflammation.
###end article-title 99
###begin article-title 100
###xml 100 108 <span type="species:ncbi:9606">children</span>
Low CD4 T cell immunity to pneumolysin is associated with nasopharyngeal carriage of pneumococci in children.
###end article-title 100
###begin article-title 101
Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media.
###end article-title 101
###begin article-title 102
Age-specific immunoglobulin g (IgG) and IgA to pneumococcal protein antigens in a population in coastal kenya.
###end article-title 102
###begin article-title 103
###xml 90 112 <span type="species:ncbi:727">Haemophilus influenzae</span>
Evaluation of bacterial polysaccharide immune globulin for the treatment or prevention of Haemophilus influenzae type b and pneumococcal disease.
###end article-title 103
###begin article-title 104
Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. Multicenter AIDS Cohort Study.
###end article-title 104
###begin article-title 105
###xml 12 32 <span type="species:ncbi:4754">Pneumocystis carinii</span>
###xml 49 52 <span type="species:ncbi:9606">men</span>
###xml 67 102 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group.
###end article-title 105
###begin article-title 106
###xml 59 64 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Invasive pneumococcal disease in a cohort of predominantly HIV-1 infected female sex-workers in Nairobi, Kenya.
###end article-title 106
###begin article-title 107
###xml 27 55 <span type="species:ncbi:12721">human immunodeficiency virus</span>
###xml 65 72 <span type="species:ncbi:9606">persons</span>
Pneumococcal disease among human immunodeficiency virus-infected persons: incidence, risk factors, and impact of vaccination.
###end article-title 107
###begin article-title 108
###xml 10 38 <span type="species:ncbi:12721">human immunodeficiency virus</span>
###xml 52 76 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
###xml 125 130 <span type="species:ncbi:9606">women</span>
Impact of human immunodeficiency virus infection on Streptococcus pneumoniae colonization and seroepidemiology among Zambian women.
###end article-title 108
###begin article-title 109
###xml 41 65 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
###xml 69 97 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Decreased serum opsonic activity against Streptococcus pneumoniae in human immunodeficiency virus-infected Ugandan adults.
###end article-title 109
###begin article-title 110
###xml 80 85 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection.
###end article-title 110
###begin article-title 111
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 infection is associated with altered innate pulmonary immunity.
###end article-title 111
###begin article-title 112
###xml 27 51 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
###xml 55 62 <span type="species:ncbi:9606">infants</span>
Epidemiological studies of Streptococcus pneumoniae in infants: antibody to types 3, 6, 14, and 23 in the first two years of life.
###end article-title 112
###begin article-title 113
###xml 53 77 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
Emergence of antibody to capsular polysaccharides of Streptococcus pneumoniae during outbreaks of pneumonia: association with nasopharyngeal colonization.
###end article-title 113
###begin article-title 114
Serum serotype-specific pneumococcal anticapsular immunoglobulin g concentrations after immunization with a 9-valent conjugate pneumococcal vaccine correlate with nasopharyngeal acquisition of pneumococcus.
###end article-title 114
###begin article-title 115
###xml 65 70 <span type="species:ncbi:9606">human</span>
The immune response to pneumococcal proteins during experimental human carriage.
###end article-title 115
###begin article-title 116
###xml 50 74 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
Protection against Nasopharyngeal Colonization by Streptococcus pneumoniae is Mediated by Antigen-Specific CD4+ T Cells.
###end article-title 116
###begin article-title 117
TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells.
###end article-title 117
###begin article-title 118
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.
###end article-title 118
###begin article-title 119
###xml 45 66 <span type="species:ncbi:573">Klebsiella pneumoniae</span>
Interleukin-17 and lung host defense against Klebsiella pneumoniae infection.
###end article-title 119
###begin article-title 120
###xml 49 65 <span type="species:ncbi:5476">Candida albicans</span>
###xml 82 86 <span type="species:ncbi:10090">mice</span>
Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice.
###end article-title 120
###begin article-title 121
###xml 62 82 <span type="species:ncbi:520">Bordetella pertussis</span>
TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells.
###end article-title 121
###begin article-title 122
IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-gamma responses if IL-12p70 is available.
###end article-title 122
###begin article-title 123
###xml 112 138 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge.
###end article-title 123
###begin article-title 124
###xml 85 93 <span type="species:ncbi:9606">children</span>
Antibodies to pneumococcal surface protein A families 1 and 2 in serum and saliva of children and the risk of pneumococcal acute otitis media.
###end article-title 124
###begin article-title 125
Intranasal immunization with killed unencapsulated whole cells prevents colonization and invasive disease by capsulated pneumococci.
###end article-title 125
###begin article-title 126
Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense.
###end article-title 126
###begin article-title 127
Nasal lymphoid tissue (NALT) as a mucosal immune inductive site.
###end article-title 127
###begin article-title 128
Surface phagocytosis; further evidence of its destructive action upon fully encapsulated pneumococci in the absence of type-specific antibody.
###end article-title 128
###begin article-title 129
###xml 89 97 <span type="species:ncbi:9606">children</span>
Mucosal immune responses to capsular pneumococcal polysaccharides in immunized preschool children and controls with similar nasal pneumococcal colonization rates.
###end article-title 129
###begin article-title 130
###xml 73 81 <span type="species:ncbi:9606">children</span>
Serum and mucosal antibody responses to pneumococcal protein antigens in children: relationships with carriage status.
###end article-title 130
###begin p 131
The authors have declared that no competing interests exist.
###end p 131
###begin p 132
The authors gratefully acknowledge support from the Pamela and Jack Egan Fund. RM is supported by grants from the National Institutes of Health (AI067737-01 and AI51526-01) and PATH. CMT and ML's work was supported by grant R01 AI048935 from the National Institutes of Health. JG was supported by the U.S. Army; DB was supported by the Ter Meulen Fund, Royal Netherlands Academy of Arts and Sciences; LB was supported by a fellowship from the European Society for Paediatric Infectious Diseases. AF and QZ are supported by a grant from SPARKS, UK. The opinions or assertions contained herein are the private views of the authors, and are not to be construed as official or reflecting the views of the Department of the Army or the Department of Defense.
###end p 132

